As of 2026-09-16, the Relative Valuation of Reata Pharmaceuticals Inc (RETA) is (67.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 172.36 USD, the upside of Reata Pharmaceuticals Inc based on Relative Valuation is -139.4%.
The range of the Relative Valuation is (45.18) - (56.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 35.1x | 30.6x |
| Forward P/E multiples | 16.7x - 21.6x | 21.4x |
| Fair Price | (45.18) - (56.45) | (67.83) |
| Upside | -126.2% - -132.8% | -139.4% |
| Date | P/E |